Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: robotics/AI

The world’s first programming language based on classical Chinese is only about a month old, and volunteers have already written dozens of programs with it, such as one based on an ancient Chinese fortune-telling algorithm.

The new language’s developer, Lingdong Huang, previously designed an infinite computer-generated Chinese landscape painting. He also helped create the first and so far only AI-generated Chinese opera. He graduated with a degree in computer science and art from Carnegie Mellon University in December.

After coming up with the idea for the new language, wenyan-lang, roughly a year ago, Huang finished the core of the language during his last month at school. It includes a renderer that can display a program in a manner that resembles pages from ancient Chinese texts.

Read more | >

I’ve been reading Scientific American for over 40 years, and it’s always giving me a good overview of topics that I’m unfamiliar with. I have come across a few recent articles on the topic of Banning Killer Robots. Here are web links to two excellent articles:

https://www.scientificamerican.com/my-account/login/?s=1

Nations racing to acquire weapons that choose their own targets are ignoring the apocalyptic scenarios that can unfold when rivals catch up.

Read more | >

This article was written by AI

Can you tell?

What are AI applications?

We need to figure that out, and that’s something the AI community is trying to figure out.”

I don’t want to see artificial intelligence replace all of us, but I do want to see a society that benefits from the use of artificial intelligence. The next 50 years will be one of the most important and transformative eras in human history, and if we don’t think about what AI is and how it will impact us as a society, we’ll get it all wrong.

Read more | >

Scientists from Tufts University, the University of Vermont, and the Wyss Institute at Harvard published early research in Proceedings of the National Academy of Sciences about robots made from heart and skin cells derived from frog embryo stem cells that they call xenobots. What does this mean for robotics and what are the ethical issues at play?

Starring tom merritt, sarah lane, len peralta, roger chang, annalee newitz.

Support Daily Tech News Show! https://www.patreon.com/dtns

Quick Hits:
https://www.theverge.com/2020/1/16/21069422/facebook-whatsapp-ads-sales-advertising-plans
https://www.theverge.com/2020/1/17/21070318/facebook-developers-data-lawsuit-competitors
https://www.thurrott.com/smart-home/228303/xiaomi-is-back-on-google-home-and-nest

Top Stories:
https://www.androidpolice.com/2020/01/17/exclusive-google-is-working-to-bring-steam-to-chrome-os/
https://www.trustedreviews.com/news/grab-google-stadia-premier-free-swish-bt-deal-3970594
https://www.cnbc.com/2020/01/17/apple-may-be-forced-to-ditch-lightning-charge-cable-amid-new-eu-rules.html
https://www.scmp.com/tech/policy/article/3046346/shanghai-introduces-facial-recognition-drug-collection-terminals-combat
https://thenextweb.com/artificial-intelligence/2020/01/17/googles-new-ai-language-models-can-comprehend-entire-books/

http://dailytechheadlines.com

Read more | >

Remember the first time you tried Apple’s Siri and went absolutely gaga over the human-like qualities of the application? Well, then came Amazon’s Alexa, a virtual assistant AI that was first available in the Amazon Dot and Amazon Echo Dot speakers but none of these were conversational as such. Although they can answer general questions about the weather and news, it will never feel really conversational.

Google, however, has in store something more conversational than the existing Siri, Alexa and Cortana in the form of its new chat companion, Meena. The company claims that it is going to be the best chatbot in the market that can talk with the user about anything on earth.

As per Google, Meena is a neutral network has about 2.6 billion parameters. “We present Meena, a multi-turn open-domain chatbot trained end-to-end on data mined and filtered from public domain social media conversations. This 2.6B parameter neural network is trained to minimize perplexity, an automatic metric that we compare against the human judgement of multi-turn conversation quality,” Google said in a blog post.

Read more | >

Using digital ai generated medicines plus human on a chip systems you could get new medicines out not in years but hours.

The next generation of MOC design at TissUse aims for a Human-on-a-Chip, increasing the number of interconnected organs toward acceptable organismal complexity. This number of organs is supposed to be efficient to provide human organismal homeostasis, sufficiently flexible for diverse disease modelling and to bear the potential of ultimately replacing animal models for systemic substance testing.

Read more | >

A swarm of autonomous robots has been deployed by researchers from DARPA to test how the technology could be used as part of an urban raid. The experiment was part of a project to find ways to map environments and gather real-time intelligence using aerial and land based robots.

In the not-so-distant future, hundreds of unmanned drones and on-the-ground rovers could swoop into an area of interest and spew crucial data to human military operators faced with limited sight lines or tasked with navigating unpredictable spaces, researchers the Defense Advanced Research Projects Agency (DARPA) said this week.

Read more | >

A drug molecule invented entirely by artificial intelligence is set to enter human clinical trials for the first time, marking a critical milestone for the role of machine learning in medicine.

The new compound, which has been designed to treat patients with obsessive-compulsive disorder, was developed by Oxford-based AI start-up Exscientia in collaboration with the Japanese pharmaceutical firm Sumitomo Dainippon Pharma.

In a sharp acceleration of the typical path to drug development, which can take about four and a half years, the AI-designed compound reached the point of entering clinical trials within just 12 months.

Read more | >